- Not yet recruitingPHASE1, PHASE2
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
This study is looking at new ways to treat advanced prostate cancer that has spread. Researchers are testing different medicines to see how safe they are, if they have side effects, and how well they work in men whose cancer hasn't responded to previous treatments.
For: Metastatic Prostate CancerUnited States · Australia · Germany - RecruitingPHASE1, PHASE2
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
This study tests a new drug, AZD9574, alone and with other treatments, for people with advanced cancers. It aims to see how safe it is, how the body handles it, and if it helps shrink tumours.
For: Advanced Solid MalignanciesUnited States · Australia · Germany - RecruitingPHASE1, PHASE2
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
This study is testing a new drug, AZD0516, for men with prostate cancer that has spread. Researchers want to see if it's safe and how well it works, both alone and with another drug, AZD9574.
For: Metastatic Prostate CancerUnited States · Brazil · China